TACE combined with various ablation therapies or immunotherapy for the treatment of PHC can also increase the body’s anti-tumor ability, mainly manifested as CD4+, CD4+/CD8+, NK cell levels increasing, CD8+ and Treg cell level decreasing, etc. (12). Here, CD8A is linked to neoplasm.